Replies to post #244280 on Biotech Values

[DewDiligence]

PCVX sells 21.6M* shares @$32.00—a 3% discount to Monday’s close—raising ~$650M* in net proceeds

https://www.globenewswire.com/news-release/2022/10/26/2541446/0/en/Vaxcyte-Announces-Pricing-of-600-Million-Public-Offering.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

PCVX has_been_consistent_about_raising capital after reporting clinical data:

https://www.globenewswire.com/news-release/2023/04/17/2648454/0/en/Vaxcyte-Announces-Commencement-of-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

The size and terms of the offering have not yet been set.